Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Light-induced LLPS of the CRY2/SPA1/FIO1 complex regulating mRNA methylation and chlorophyll homeostasis in Arabidopsis. | Nat Plants | 2023 | 38066290 | PubTator, text mining | PubMed |
| METTL3/YTHDC1-medicated m6A modification of circRNA3634 regulates the proliferation and differentiation of antler chondrocytes by miR-124486-5-MAPK1 axis. | Cell Mol Biol Lett | 2023 | 38062349 | PubTator, text mining | PubMed |
| How to enhance the ability of mesenchymal stem cells to alleviate intervertebral disc degeneration. | World J Stem Cells | 2023 | 38058958 | PubTator, text mining | PubMed |
| KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN. | Heliyon | 2023 | 38058614 | PubTator, text mining | PubMed |
| GATA6-AS1 suppresses epithelial-mesenchymal transition of pancreatic cancer under hypoxia through regulating SNAI1 mRNA stability. | J Transl Med | 2023 | 38057853 | PubTator, text mining | PubMed |
| m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer. | BMC Endocr Disord | 2023 | 38057752 | PubTator, text mining | PubMed |
| Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses. | PLoS One | 2023 | 38055673 | PubTator, text mining | PubMed |
| TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination. | Neoplasma | 2023 | 38053376 | PubTator, text mining | PubMed |
| Effects of RNA methylation on Tumor angiogenesis and cancer progression. | Mol Cancer | 2023 | 38053093 | PubTator, text mining | PubMed |
| Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy. | Cell Death Dis | 2023 | 38052820 | PubTator, text mining | PubMed |
| Coilin mediates m6A RNA methylation through phosphorylation of METTL3. | Biol Open | 2023 | 38050869 | PubTator, text mining | PubMed |
| NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication. | PLoS Pathog | 2023 | 38048324 | PubTator, text mining | PubMed |
| METTL16 in human diseases: What should we do next? | Open Med (Wars) | 2023 | 38045858 | PubTator, text mining | PubMed |
| Fentanyl Promoted the Growth of Placenta Trophoblast Cells through Regulating the METTL14 Mediated CCL5 Levels. | Biol Pharm Bull | 2023 | 38044098 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68. | Eur J Med Res | 2023 | 38042806 | PubTator, text mining | PubMed |
| The role of post-transcriptional regulation in SARS-CoV-2 infection and pathogenicity. | Front Immunol | 2023 | 38035086 | PubTator, text mining | PubMed |
| Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases. | Cell Commun Signal | 2023 | 38031146 | PubTator, text mining | PubMed |
| Identification and validation of N6-methyladenosine (m6A)-related lncRNAs signature for predicting the prognosis of laryngeal carcinoma, especially for smoking patients. | Front Genet | 2023 | 38028627 | PubTator, text mining | PubMed |
| M6A RNA methylation modification and tumor immune microenvironment in lung adenocarcinoma. | Biophys Rep | 2023 | 38028153 | PubTator, text mining | PubMed |
| Global m6A methylation and gene expression patterns in human microglial HMC3 cells infected with HIV-1. | Heliyon | 2023 | 38027859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=36